Can low-dose testosterone selectively control which masculinizing effects you get?

What did @tikdoctony actually say?

Dr. Tony claims that low-dose testosterone lets people "control the changes" they want, specifically singling out voice lowering as achievable at doses low enough to avoid or delay muscle bulk, facial hair, and what he calls "bottle growth" (clitoral growth). His pitch: work with a doctor to find the "lowest dose that will actually have an effect" and you can essentially customize your masculinization timeline.

He frames this as a practical harm-reduction strategy for trans and nonbinary individuals who want some effects of testosterone, like a lower voice, without the full masculinizing package. That framing is not inherently wrong, but it oversimplifies how testosterone physiology actually works in ways that could set real expectations that don't hold up.

Does the science back this up?

Partially, but not in the clean, controllable way he implies. Testosterone's effects are dose-dependent, but individual variation is enormous, and there is no dose that reliably produces voice changes while guaranteeing the absence of other effects. The evidence does support that lower doses produce slower, more gradual changes overall. That part is solid.

What the research does not support is the idea that you can neatly isolate voice changes from other androgenic effects. A 2019 study by T'Sjoen et al. in Endocrine Reviews confirmed that androgenic sensitivity varies significantly by tissue type and individual genetics, meaning the same dose can trigger clitoral growth in one person before any voice change, and do the opposite in another. Olson-Kennedy et al. (2018, Pediatrics) similarly found that masculinization timelines across different body systems are not linearly correlated with dose. Low dose slows everything down, but does not give you a menu.

What did they get wrong (or right)?

Credit where it is due: Dr. Tony is right that voice changes tend to appear relatively early in testosterone therapy, and that lower doses produce more gradual overall changes. A 2020 study by Ziegler et al. in Journal of Voice documented voice pitch reduction as one of the earlier-onset effects of testosterone, beginning within the first few months of therapy. He is also right to emphasize working with a doctor to find an individualized dose.

Where he goes wrong is suggesting that "bottle growth" specifically can be avoided or meaningfully deferred by controlling dose. Clitoral growth is among the most sensitive androgenic responses in many individuals. Research from Nakamura et al. (2021, Endocrine Practice) found clitoral growth occurring even at relatively low serum testosterone levels. The framing that low-dose T lets you get a lower voice "without those changes" is clinically inaccurate for many patients and risks creating false expectations.

• Correct: Voice changes are among the earlier effects of testosterone therapy.
• Correct: Lower doses produce more gradual changes overall.
• Incorrect: You can reliably get voice changes while avoiding clitoral growth or other early androgenic effects.
• Missing: Individual genetic variation in androgen receptor sensitivity makes these timelines highly unpredictable.

What should you actually know?

Low-dose testosterone is a legitimate clinical approach used in gender-affirming care, particularly for patients who want gradual or partial masculinization. But "control" here means slowing down a process, not selecting specific outcomes from a list. Your androgen receptors do not read your preference sheet.

The more honest framing is this: lower doses mean slower changes across the board, and some changes may appear before others based on your individual biology, not the dose you choose. A 2022 clinical review by Abern and Maguire in Urology Clinics of North America emphasized that patient counseling for low-dose regimens should explicitly address that inter-individual variability is high enough to make effect prediction unreliable.

If you are considering low-dose testosterone for gender-affirming purposes, a specialized endocrinologist or gender-affirming care provider can monitor hormone levels and titrate accordingly. Monitoring serum testosterone, estradiol, hematocrit, and lipids regularly is standard of care. The goal of "customization" is achievable to a degree, but only through ongoing clinical monitoring, not by choosing a dose and expecting a predictable menu of results.

Bottom line

Dr. Tony's video is well-intentioned and not dangerous, but it overpromises what low-dose testosterone can actually deliver in terms of selective effects. The claim that you can specifically get a lower voice while avoiding clitoral growth is not well-supported by endocrinology literature. Individual variation dominates these outcomes far more than dose selection alone does. Patients deserve that honest caveat before starting therapy.